Full name
TRANSMEDIUM SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
TRANSMEDIUM SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. GOŁUŃSKA 21, 80-178 GDAŃSK
TAX ID9571069113
Rate company:
TRANSMEDIUM SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID9571069113
KRS0000463378
Share capital74,200.00 zł
address
UL. GOŁUŃSKA 21, 80-178 GDAŃSK
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
9571069113
REGON
221889873
KRS
0000463378
Legal form
limited liability company
Register Address
UL. GOŁUŃSKA 21, 80-178 GDAŃSK
Date of registration in KRS
2013-05-24
Date of commencement of economic activity
2013-05-24
Act signature
RDF/646006/24/868
Pkd codes
72.11.Z - Research and experimental development on biotechnology
32.50.Z - Manufacture of medical and dental instruments and supplies
32.99.Z - Other manufacturing notelsewhere classified
70.22.Z - Business and other management consultancy activities
71.20.B - Other technical testing and analysis
72.19.Z - Other research and experimental development on natural sciences and engineering
74.10.Z - Specialised design activities
77.39.Z - Rental and leasing of other machinery, equipment and tangible goods not elsewhere classified
77.40.Z - Leasing of intellectual property and similar products, except copyrighted works
85.59.B - Other out-of-school forms of education, not elsewhere classified
Payer VAT status
Active
Vat list bank account(s)
PL74 1240 5400 1111 0010 5095 6839 
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss)  | -9,5 | -12,5 | -17,1 | -36,4 |
EBITDA | -9,1 | -12 | -15 | -25,8 |
Short time liabilities | 17 | 0,4 | 8,2 | 1720,7 |
Equity capital | 35,4 | 30,7 | 23 | -25 |
Operating profit (EBIT) | -9,1 | -12 | -15 | -25,8 |
Assets | 52,4 | 51,7 | 51,7 | 0,1 |
Net profit (loss) | -9,5 | -12,5 | -17,1 | -36,4 |
Cash | 0,5 | 1 | 0,7 | -31,4 |
Liabilities and provisions for liabilities | 17 | 21 | 28,7 | 36,8 |
Net income from sale | 0 | 0,1 | 4,1 | 8175,8 |
Working assets | 4,1 | 3,4 | 3,4 | 2 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | -26,9 | -40,9 | -74,3 | -33,4 |
Equity capital to total assets | 67,5 | 59,3 | 44,5 | -14,8 |
Gross profit margin | -25 069,7 | -413,3 | 24 656,4 | |
EBITDA Margin | -23 916 | -363,6 | 23 552,4 | |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 3274 | 720 | -2554 |
Current financial liquidity indicator | 0.24139057099819183 | 7.470702648162842 | 0.4185287356376648 | -7,1 |
Net dept to EBITDA | -1.8243905305862427 | -1.6331819295883179 | -1.8547685146331787 | -0,3 |
Financial statements
01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download pdf01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdf01-01-2023 - 31-12-2023
Activity report
Download pdf01-01-2023 - 31-12-2023
Annual financial report
Download xmlShow more (1)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
SciencePlast Sp. z o.o.
Gdansk